Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Madrigal Pharmaceuticals Inc (NASDAQ:MDGL)

15.41
Delayed Data
As of 10:58am ET
 -0.29 / -1.85%
Today’s Change
6.60
Today|||52-Week Range
18.24
+3.42%
Year-to-Date
No recent news for Madrigal Pharmaceuticals Inc.

Today’s Trading

Previous close15.70
Today’s open15.51
Day’s range15.39 - 15.74
Volume2,405
Average volume (3 months)26,286
Market cap$181.6M
Dividend yield--
Data as of 10:58am ET, 02/23/2017

Growth & Valuation

Earnings growth (last year)+39.08%
Earnings growth (this year)+62.91%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book1.23

Competitors

 Today’s
change
Today’s
% change
GNMXAevi Genomic Medicin...-0.21-4.29%
CLSDClearside Biomedical...-0.64-8.90%
--China Health Group I...+0.00+0.57%
NYMXNymox Pharmaceutical...0.000.00%
Data as of 11:22am ET, 02/23/2017

Financials

Next reporting dateMarch 16, 2017
EPS forecast (this quarter)-$1.39
Annual revenue (last year)$0.00
Annual profit (last year)-$68.7M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman, President &
Chief Executive Officer
Paul A. Friedman
Chief Financial Officer &
Senior Vice President
Marc R. Schneebaum
Corporate headquarters
Fort Washington, Pennsylvania

Forecasts


Search for Jobs